COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER
- Other title
- COMPARAISON ENTRE LE PHOSPHATE D'ESTRAMUSTINE, LE METHOTREXATE ET LE CIS-PLATINUM CHEZ LES SUJETS AYANT UN CANCER AVANCE DE LA PROSTATE HORMONORESISTANT (fr)
- Author
- LOENING SA; BECKLEY S; BRADY MF; CHU TM; DEKERNION JB; DHABUWALA C; GAETA JF; GIBBONS RP; MCKIEL CF; MCLEOD DG; PONTES JE; PROUT GR; SCARDINO PT; SCHLEGEL JU; SCHMIDT JD; SCOTT WW; SLACK NH; SOLOWAY MS; MURPHY GP
UNIV. IOWA HOSP./IOWA CITY IA/USA - Source
- JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 5; PP. 1001-1006; ABS. ENG; BIBL. 25 REF.; GRAPH
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- TUMEUR PROSTATE STADE AVANCE CHIMIOTHERAPIE METHOTREXATE CISPLATINE ESTRACYT ETUDE COMPARATIVE ANTICANCEREUX PLATINE II COMPLEXE HORMONE TRAITEMENT ANTIMETABOLITE APPAREIL GENITAL MALE PATHOLOGIE HOMME PHARMACOLOGIE
- Keyword (en)
- TUMOR PROSTATE ADVANCED STAGE CHEMOTHERAPY ESTRACYT COMPARATIVE STUDY ANTINEOPLASTIC AGENT PLATINUM II COMPLEXES HORMONE TREATMENT ANTIMETABOLIC MALE GENITAL SYSTEM PATHOLOGY HUMAN PHARMACOLOGY
- Keyword (es)
- FARMACOLOGIA
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Discipline
- General pharmacology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- PASCAL83X0457884
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:9:\"\u0000*\u0000jtitle\";s:0:\"\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"1983\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:0:\"\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"LOENING\";s:10:\"\u0000*\u0000aufirst\";s:2:\"SA\";s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:18:{i:0;s:9:\"BECKLEY S\";i:1;s:8:\"BRADY MF\";i:2;s:6:\"CHU TM\";i:3;s:12:\"DEKERNION JB\";i:4;s:11:\"DHABUWALA C\";i:5;s:8:\"GAETA JF\";i:6;s:10:\"GIBBONS RP\";i:7;s:9:\"MCKIEL CF\";i:8;s:9:\"MCLEOD DG\";i:9;s:9:\"PONTES JE\";i:10;s:8:\"PROUT GR\";i:11;s:11:\"SCARDINO PT\";i:12;s:11:\"SCHLEGEL JU\";i:13;s:10:\"SCHMIDT JD\";i:14;s:8:\"SCOTT WW\";i:15;s:8:\"SLACK NH\";i:16;s:10:\"SOLOWAY MS\";i:17;s:9:\"MURPHY GP\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:8:\"\u0000*\u0000place\";s:0:\"\";s:6:\"\u0000*\u0000pub\";s:0:\"\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:9:\"\u0000*\u0000jtitle\";s:0:\"\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"1983\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:0:\"\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"LOENING\";s:10:\"\u0000*\u0000aufirst\";s:2:\"SA\";s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:18:{i:0;s:9:\"BECKLEY S\";i:1;s:8:\"BRADY MF\";i:2;s:6:\"CHU TM\";i:3;s:12:\"DEKERNION JB\";i:4;s:11:\"DHABUWALA C\";i:5;s:8:\"GAETA JF\";i:6;s:10:\"GIBBONS RP\";i:7;s:9:\"MCKIEL CF\";i:8;s:9:\"MCLEOD DG\";i:9;s:9:\"PONTES JE\";i:10;s:8:\"PROUT GR\";i:11;s:11:\"SCARDINO PT\";i:12;s:11:\"SCHLEGEL JU\";i:13;s:10:\"SCHMIDT JD\";i:14;s:8:\"SCOTT WW\";i:15;s:8:\"SLACK NH\";i:16;s:10:\"SOLOWAY MS\";i:17;s:9:\"MURPHY GP\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:8:\"\u0000*\u0000place\";s:0:\"\";s:6:\"\u0000*\u0000pub\";s:0:\"\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:9:\"\u0000*\u0000jtitle\";s:0:\"\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"1983\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:0:\"\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"LOENING\";s:10:\"\u0000*\u0000aufirst\";s:2:\"SA\";s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:18:{i:0;s:9:\"BECKLEY S\";i:1;s:8:\"BRADY MF\";i:2;s:6:\"CHU TM\";i:3;s:12:\"DEKERNION JB\";i:4;s:11:\"DHABUWALA C\";i:5;s:8:\"GAETA JF\";i:6;s:10:\"GIBBONS RP\";i:7;s:9:\"MCKIEL CF\";i:8;s:9:\"MCLEOD DG\";i:9;s:9:\"PONTES JE\";i:10;s:8:\"PROUT GR\";i:11;s:11:\"SCARDINO PT\";i:12;s:11:\"SCHLEGEL JU\";i:13;s:10:\"SCHMIDT JD\";i:14;s:8:\"SCOTT WW\";i:15;s:8:\"SLACK NH\";i:16;s:10:\"SOLOWAY MS\";i:17;s:9:\"MURPHY GP\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:8:\"\u0000*\u0000place\";s:0:\"\";s:6:\"\u0000*\u0000pub\";s:0:\"\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:9:\"\u0000*\u0000jtitle\";s:0:\"\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"1983\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:0:\"\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"LOENING\";s:10:\"\u0000*\u0000aufirst\";s:2:\"SA\";s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:18:{i:0;s:9:\"BECKLEY S\";i:1;s:8:\"BRADY MF\";i:2;s:6:\"CHU TM\";i:3;s:12:\"DEKERNION JB\";i:4;s:11:\"DHABUWALA C\";i:5;s:8:\"GAETA JF\";i:6;s:10:\"GIBBONS RP\";i:7;s:9:\"MCKIEL CF\";i:8;s:9:\"MCLEOD DG\";i:9;s:9:\"PONTES JE\";i:10;s:8:\"PROUT GR\";i:11;s:11:\"SCARDINO PT\";i:12;s:11:\"SCHLEGEL JU\";i:13;s:10:\"SCHMIDT JD\";i:14;s:8:\"SCOTT WW\";i:15;s:8:\"SLACK NH\";i:16;s:10:\"SOLOWAY MS\";i:17;s:9:\"MURPHY GP\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:8:\"\u0000*\u0000place\";s:0:\"\";s:6:\"\u0000*\u0000pub\";s:0:\"\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:9:\"\u0000*\u0000jtitle\";s:0:\"\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"1983\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:0:\"\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"LOENING\";s:10:\"\u0000*\u0000aufirst\";s:2:\"SA\";s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";a:18:{i:0;s:9:\"BECKLEY S\";i:1;s:8:\"BRADY MF\";i:2;s:6:\"CHU TM\";i:3;s:12:\"DEKERNION JB\";i:4;s:11:\"DHABUWALA C\";i:5;s:8:\"GAETA JF\";i:6;s:10:\"GIBBONS RP\";i:7;s:9:\"MCKIEL CF\";i:8;s:9:\"MCLEOD DG\";i:9;s:9:\"PONTES JE\";i:10;s:8:\"PROUT GR\";i:11;s:11:\"SCARDINO PT\";i:12;s:11:\"SCHLEGEL JU\";i:13;s:10:\"SCHMIDT JD\";i:14;s:8:\"SCOTT WW\";i:15;s:8:\"SLACK NH\";i:16;s:10:\"SOLOWAY MS\";i:17;s:9:\"MURPHY GP\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER\";s:8:\"\u0000*\u0000place\";s:0:\"\";s:6:\"\u0000*\u0000pub\";s:0:\"\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
